跳至主要内容
临床试验/CTRI/2025/06/088730
CTRI/2025/06/088730尚未招募4 期

An open label single arm clinical study to evaluate the combined efficiency of Madhutailika basti and Kamini vidravana rasa in the management of Klaibya vis a vis Erectile dysfunction

DR SIDDALINGA SWAMY J M1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年6月30日最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
30
试验地点
1
主要终点
Increases in the scoring of IIEF.

研究概览

简要总结

Erectile dysfunction (ED) is the failure to achieve erection, ejaculation, or both. It affects 10-25% of middle-aged and elderly men. ED may result from three basic mechanisms: failure to initiate (psychogenic, endocrinologic, or neurogenic); failure to fill (arteriogenic); and failure to store adequate blood volume within the lacunar network (vasculogenic dysfunction). ED is the most common burning issue in males, recent hospital-based study from Southern India has reported the prevalences of ED and Premature ejaculation to be 48% and 43%, respectively. ED is a major cause of Impotency. In Western medical science, the management of ED includes oral medication Phosphodiesterase (PDE) 5 inhibitors (sildenafil, Tadalafil), Testosterone replacement, Androgen therapy, Intra urethral alprostadil, and intra cavernosal injection. These hormonal therapies have their own complications such as patients may experience Nausea, Bradycardia, Gastric irritation, and Bloating of the guts. Prolonged usage of such medications leads to Gynecomastia, Obscured vision, photophobia, stomach and pelvic pain, Benign Prostatic Hyperplasia, and Prostatic cancer. These treatment modalities have limitations, not feasible, time-consuming, expensive, are not patient-friendly. The absence of sexual function hampers marital relationships and sometimes ends in divorce. Thus there is a need to develop an elective and viable management to overcome the burning issue in the present day. Klaibya / kleebata which is mentioned under Shukravaha srotovikara in Ayurveda can be co related to Erectile dysfunction. Klaibya is defined as “Klaibyam Ithi Dvajanucharyam”, the condition in which lack of erection/absence of erection is due to distinct etiological factors. Ayurveda opines that the pathophysiology of klaibya is mainly due to Shukravaha srotodusti and Vatadosha, among these Charaka Samhita specifies the involvement of Vyana and Apana vayu. To get over this condition, and for vitiated vatadosha, Basti5 is the best line of treatment. hence they basically concentrate on Madhutailika basti6 as prime Vrishya basti, because it has properties like Vyapadam cha api asambhavaha and no specific parihara Vishaya should be followed. Kamini vidravana rasa is one such Rasoushadi said to be a vrishya. It is a Herbo-mineral medicine and has aphrodisiac properties that play an important role in the management of ED. It has the potential to improve sexual performance by improving stamina, Vigor, hardness of organ, and delaying the time of ejaculation. The study intends to evaluate the combined effect of Madhutailika basti and kaminin vidravana rasa.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
21.00 Year(s) 至 59.00 Year(s)(—)
性别
Male

入选标准

  • Both fresh cases and treated cases will be included.
  • The definition of fresh cases includes freshly diagnosed and untreated cases of ED.
  • The definition of treated cases includes already diagnosed and treated cases of ED who had voluntarily discontinued the treatment with a flush-out period of 7 days.

排除标准

  • • Subjects with systemic and structural deformities such as Cryptochidism, Varicoceal grade 3, and Peyronie’s disease, will be excluded.
  • • Post-traumatic ED will be excluded.
  • • Subjects suffering from sexually transmitted disease (STD), Human immunodeficiency virus (HIV), Hepatitis C virus (HCV), and Tuberculosis (TB) will be excluded.
  • • Subjects with uncontrolled Diabetes mellitus i.e. FBS more than 200mg per dL and PPBS more than 250 mg per dL will be excluded.
  • • Subjects with Stage 2 Hypertension (more than 160 by 100) will be excluded.
  • • Chronic Alcoholism will be excluded.
  • • Major psychiatric illness associated with ED will be excluded.
  • • ED more than 10 years will be excluded.
  • • Subjects who are unfit for Basti will be excluded.
  • • Subjects with other systemic disorders that interfere with the intervention will be excluded.

结局指标

主要结局

Increases in the scoring of IIEF.

时间窗: 0th day, 46th day

次要结局

  • Increase in the grading(45 days)

研究者

发起方
DR SIDDALINGA SWAMY J M
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Siddalinga swamy J M

Government Ayurveda Medical College ,Mysuru

研究点 (1)

Loading locations...

相似试验